Dag Aarsland Selected Research

Cholinesterase Inhibitors (Anticholinesterases)

1/2022	Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.
10/2020	Psychosis in Alzheimer's Disease.
9/2017	New Therapeutic Strategies for Lewy Body Dementias.
1/2017	Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.
1/2017	Importance of Proactive Treatment of Depression in Lewy Body Dementias: The Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study.
1/2016	Cognitive impairment in Parkinson's disease and dementia with Lewy bodies.
8/2013	Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management.
1/2013	Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem).
10/2011	Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data.
4/2011	Mania after administration of cholinesterase inhibitors in patients with dementia and comorbid bipolar disorder: two case reports.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dag Aarsland Research Topics

Disease

149	Dementia (Dementias) 01/2022 - 04/2004
78	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2004
72	Cognitive Dysfunction 12/2022 - 09/2004
67	Parkinson Disease (Parkinson's Disease) 01/2022 - 09/2004
15	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2006
15	Lewy Body Disease (Lewy Body Dementia) 09/2021 - 03/2006
12	Atrophy 01/2022 - 01/2006
12	Hallucinations (Hallucination) 01/2021 - 11/2006
10	Pain (Aches) 01/2019 - 07/2008
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2009
7	Parkinsonian Disorders (Parkinsonism) 01/2019 - 05/2005
6	Disease Progression 01/2020 - 01/2013
5	Inflammation (Inflammations) 01/2022 - 01/2019
4	Amyloid Plaque 01/2018 - 08/2011
3	Neuroinflammatory Diseases 01/2022 - 09/2014
3	Hypertension (High Blood Pressure) 01/2021 - 01/2016
3	Genetic Risk Score 01/2021 - 01/2017
3	REM Sleep Behavior Disorder 01/2018 - 08/2010
3	Neuroblastoma 11/2016 - 05/2015
3	Orthostatic Hypotension (Postural Hypotension) 05/2014 - 01/2009
2	Stroke (Strokes) 01/2021 - 01/2019
2	Neurobehavioral Manifestations 01/2018 - 01/2017
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2016 - 05/2010
2	Mixed Dementias 10/2016 - 07/2008
2	Mania (Manias) 04/2011 - 01/2005
1	Panic Disorder (Panic Attack) 01/2022
1	Mood Disorders (Mood Disorder) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022

Drug/Important Bio-Agent (IBA)

59	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
36	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2011
20	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2008
18	Pharmaceutical PreparationsIBA 12/2020 - 12/2004
14	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022 - 04/2004
14	Apolipoproteins E (ApoE)IBA 01/2022 - 09/2009
14	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 04/2004
12	Cholinergic Agents (Cholinergics)IBA 11/2019 - 09/2004
12	SynucleinsIBA 01/2019 - 01/2012
9	Memantine (Namenda)FDA Link 01/2016 - 07/2009
9	Rivastigmine (Exelon)FDA LinkGeneric 08/2012 - 12/2004
8	Antidepressive Agents (Antidepressants)IBA 01/2021 - 11/2011
7	ApolipoproteinsIBA 01/2020 - 09/2009
7	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020 - 06/2004
6	pimavanserinIBA 01/2022 - 01/2017
6	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2014
6	alpha-SynucleinIBA 01/2021 - 12/2008
6	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2020 - 01/2010
5	Biological ProductsIBA 01/2022 - 10/2016
5	AntibodiesIBA 08/2021 - 03/2010
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2016
5	LipidsIBA 01/2021 - 06/2015
5	NeurograninIBA 11/2020 - 11/2016
5	Amyloid beta-PeptidesIBA 02/2019 - 09/2004
5	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2018 - 07/2011
5	Analgesics (Analgesic Drugs)IBA 01/2018 - 04/2012
4	Galantamine (Galanthamine)FDA LinkGeneric 01/2022 - 01/2004
4	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022 - 12/2005
4	Anthocyanins (Anthocyanin)IBA 01/2021 - 11/2016
4	Pemetrexed (MTA)FDA Link 12/2020 - 03/2015
4	Buprenorphine (Subutex)FDA LinkGeneric 01/2018 - 07/2011
3	AutoantibodiesIBA 08/2021 - 01/2015
3	tau Proteins (tau Protein)IBA 01/2020 - 10/2010
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2020 - 02/2010
3	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 07/2009
3	EnzymesIBA 01/2018 - 01/2017
3	Serotonin (5 Hydroxytryptamine)IBA 01/2016 - 01/2008
3	Opioid Analgesics (Opioids)IBA 01/2016 - 07/2008
3	hydroxide ionIBA 05/2014 - 01/2009
2	Peptides (Polypeptides)IBA 01/2022 - 01/2017
2	Donepezil (Aricept)FDA LinkGeneric 10/2021 - 01/2004
2	BenzodiazepinesIBA 01/2021 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2012
2	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2020 - 11/2019
2	zinc-binding protein (zinc binding protein)IBA 01/2020 - 12/2014
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 01/2017
2	KynurenineIBA 01/2019 - 01/2019
2	NeopterinIBA 01/2019 - 01/2019
2	Tryptophan (L-Tryptophan)FDA Link 01/2019 - 01/2019
2	C-Reactive ProteinIBA 01/2019 - 06/2015
2	Glucosylceramidase (Glucocerebrosidase)IBA 01/2018 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2012
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2018 - 01/2018
2	Clozapine (Clozaril)FDA LinkGeneric 09/2017 - 01/2015
2	Protein Isoforms (Isoforms)IBA 01/2017 - 01/2011
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2017 - 01/2016
2	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2016 - 06/2004
2	ButyrylcholinesteraseIBA 01/2016 - 11/2006
2	Morphine (MS Contin)FDA LinkGeneric 07/2014 - 07/2011
2	Antiparkinson Agents (Antiparkinsonian Agents)IBA 09/2008 - 01/2005
1	Escitalopram FDA Link 01/2022
1	LithiumIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022
1	SolutionsIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022

Therapy/Procedure

15	Therapeutics 01/2022 - 01/2006
15	Home Nursing (Nursing, Home) 01/2021 - 06/2007
13	Activities of Daily Living (ADL) 12/2022 - 01/2004
2	Cognitive Training 01/2018 - 04/2017
2	Pain Management 09/2014 - 07/2014
2	Transdermal Patch 07/2014 - 07/2011